RVTY (PerkinElmer) Market Value to Book Value Ratio

Revvity (RVTY) - corporate logo

Revvity, Inc. (RVTY) has completed a large-scale spin-off, focusing on organically increasing margins and integrating assets. The market-to-book ratio illustrates this search for equilibrium, with the metric currently standing at 2.48. The transformation into the life-science sector with an emphasis on reagents creates a foundation for growth. Stability is ensured by the supply of software and equipment to global clinics and institutions.

RVTY - Revvity Corp Market-to-Book Ratio over the range 02/21/2024 - 10/27/2026
Flagship merchandise of PerkinElmer

Revvity, Inc. (RVTY) is strengthening its leadership in biomedicine through the integration of IT services and diagnostic alliances, creating high added value for its assets. The market-to-book ratio digitizes this premium, demonstrating the extent to which the market values business synergies above its book value, which allows the premium of the market valuation over the balance sheet to distinguish fundamental growth from a value trap.

Direct competitors

Market Cap to Net Assets Ratio A|DGX (questdiagnostics.com) - Market-to-Book Ratio|Market Value to Book Value Ratio ILMN|Market Cap to Net Assets Ratio Exact Sciences Corp|Bio-Rad Laboratories Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Anbio Corp (NNNN)|SHC - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio quidel.com QDEL|OPKO Health - Market Capitalization to Book Value Ratio|CDNA: Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Maravai LifeSciences Corp|Fulgent (FLGT) - Capitalization to Book Value Ratio|LAB (Standard BioTools Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio CTKB|Market Value to Book Value Ratio OraSure (OSUR)|Market Value to Book Value Ratio exagen.com XGN|MDXH: Market Cap to Net Assets Ratio|Lucid Diagnostics, Inc - Market-to-Book Ratio|Market Value to Book Value Ratio PRE (Prenetics Global Ltd)|IMDX - Market Capitalization to Book Value|trinitybiotech.com - Market Capitalization to Book Value Ratio|PRPH (ProPhase Labs Inc) - Market Capitalization to Book Value|AIMD: Market Value to Book Value Ratio|Market Capitalization to Book Value CODX|Heart Test Laboratories (HSCS) - Market Value to Book Value Ratio|Market Value to Book Value biomerica.com (BMRA)|CDIO: Market Capitalization to Book Value Ratio|VRAX - Market-to-Book Ratio|BJDX - Market Cap to Net Assets Ratio|Aspira Women's Health Inc (AWH) - Market Value to Book Value Ratio|Accelerate Diagnostics (AXDX) - Market Cap to Net Assets Ratio|CENTOGENE (CNTG) - Market Value to Book Value Ratio|ENZ: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Fresh2 (FRES)|Market Cap to Net Assets Ratio Genetic Technologies|Market Cap to Book Value Multiple 23andMe Inc ME|PMD: Market Cap to Net Assets Ratio